Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
7MAY

Bangladesh and Cambodia keep the poultry H5N1 line

4 min read
15:24UTC

A child in Bangladesh died on 1 February after household poultry contact, and Cambodia has logged three H5N1 human cases in 2026, taking the global total outside the US dairy pathway to four.

ScienceDeveloping
Key takeaway

Asian poultry H5N1 and US dairy H5N1 are different clades on different exposure pathways; bundling the case totals obscures both.

CIDRAP reported that a child in Bangladesh died on 1 February 2026 after household poultry contact, infected with a viral clade that has circulated in local poultry since around 2011 1. Cambodia has logged three H5N1 human cases through 2026 to date. The global 2026 H5N1 human-case total outside the US dairy pathway sits at four. None of these involves dairy cattle, and all involve traditional backyard or smallholder poultry exposure.

South and Southeast Asian poultry H5N1 has been an endemic, household-scale threat for more than a decade. The clades involved tend to descend from Goose/Guangdong-lineage viruses, with regional reassortants in Bangladesh and Cambodia that diverged from the European and American clade 2.3.4.4b lines years ago. Exposure typically follows a recognisable pattern: a child or carer slaughters, plucks or feeds infected birds in a domestic compound, and the virus enters via mucosal contact rather than aerosol. Mortality among confirmed human cases on this pathway runs above 50% historically, far higher than the US dairy cohort, where workers have largely presented with conjunctivitis and mild respiratory symptoms.

The two threads matter for surveillance arithmetic. A bare global tally of H5N1 human cases lumps the Americas dairy cohort with the persistent Asian poultry pipeline and presents the trend as one curve. The structural picture is two curves on different y-axes: a wider mammalian dairy reservoir on one side, with low individual lethality but novel host range, and a long-running bird-to-human poultry pathway on the other, with higher individual lethality but a well-understood transmission ecology. Each pathway calls for a different intervention design. Smallholder poultry biosecurity in rural Bangladesh and Cambodia is a development and veterinary-extension question; California milking-parlour ventilation is an occupational-health and PPE question.

WHO and national agencies write monthly H5N1 risk assessments off cumulative case counts; if those counts are presented without the structural split, the global signal can read as runaway when one half is structurally novel and the other is a long-running endemic baseline. The separation also matters for vaccine prioritisation, where a stockpiled candidate matched to clade 2.3.4.4b will not necessarily protect against the Bangladesh or Cambodian lineages. Calibrated reporting, in this case, is not a stylistic preference but a precondition for sensible policy.

Deep Analysis

In plain English

H5N1 has been circulating in poultry in Bangladesh, Cambodia, and neighbouring countries since the early 2000s. People who keep chickens or ducks at home can catch it by handling sick birds. The child in Bangladesh who died in February 2026 caught it this way. This is a different H5N1 story from the US dairy-farm situation. The dairy route spreads in cattle milking sheds and involves occupational exposure for adult farm workers. The poultry route involves backyard birds and often affects children and women who handle household flocks. The two are running at the same time but represent two different epidemiological problems with different interventions needed.

Deep Analysis
Root Causes

Bangladesh and Cambodia share a smallholder poultry system in which backyard ducks and chickens live in close proximity to rural households. H5N1 in this system is not controlled by the same commercial-flock biosecurity infrastructure that applies to large US or European poultry operations: no all-in/all-out flock management, minimal veterinary surveillance, and limited culling capacity when cases occur.

The viral clade circulating in Bangladesh poultry has been present since approximately 2011, meaning it has been co-circulating with human populations for 15 years without acquiring human-to-human transmission capability at detectable rates.

The 2026 reporting also reflects the structural sensitivity gap: Cambodia's three cases were detected because Cambodia has an established H5N1 human surveillance system, built with US CDC and WHO support following the 2004-06 Cambodian H5N1 cluster. States without that infrastructure, including several Mekong neighbours, almost certainly have comparable exposure rates with lower detection sensitivity.

What could happen next?
  • Consequence

    WHO will continue monitoring the Southeast Asian poultry-contact pathway under standard IHR notification procedures; neither the Bangladesh nor the Cambodia cases in 2026 independently triggers new response measures beyond routine case investigation.

    Immediate · 0.9
  • Risk

    The simultaneous global circulation of the 2.3.4.4b clade in US dairy mammals and older clades in Southeast Asian poultry creates conditions for potential reassortment if a bird or mammal host becomes co-infected with both lineages; GISAID genomic surveillance is the early-warning system for this scenario.

    Medium term · 0.3
  • Opportunity

    CEPI's Moderna mRNA H5N1 Phase 3 trial, which targets 2.3.4.4b, would not automatically confer equivalent protection against the Bangladesh clade; the WHO strain-selection committee will need to track whether any Phase 3 candidate covers both clade groups before stockpile decisions are made.

    Medium term · 0.65
First Reported In

Update #1 · Hantavirus comes ashore; H5N1 won't quit

CIDRAP· 7 May 2026
Read original
Different Perspectives
NTI Bio and Resolve to Save Lives
NTI Bio and Resolve to Save Lives
NTI Bio and Resolve to Save Lives have consistently argued that the WHA Pandemic Agreement's Pathogen Access and Benefit-Sharing annex is its operational core. A failed PABS outcome at WHA79 in late May leaves the treaty without a legal mechanism for rapid vaccine sharing.
UK Health Security Agency
UK Health Security Agency
UKHSA confirmed on 6 May that British nationals are among MV Hondius cases and placed the UK in the European secondary-monitoring picture. UKHSA's active monitoring obligation covers Andes-specific person-to-person transmission risk, not generic hantavirus protocol.
Africa CDC and ASLM
Africa CDC and ASLM
Africa CDC and ASLM launched ARILAC in Addis Ababa on 6 May alongside the EU, targeting AMR laboratory capacity in 8 AU states where 1.3% of assessed labs currently conduct routine resistance testing.
CEPI (Coalition for Epidemic Preparedness Innovations)
CEPI (Coalition for Epidemic Preparedness Innovations)
CEPI announced on 22 April that Moderna's mRNA H5N1 vaccine candidate entered Phase 3 trial. CEPI's position is that pre-pandemic efficacy data collected now is the only credible path to a 100 Days Mission authorisation if H5N1 achieves sustained human-to-human spread.
World Health Organization
World Health Organization
WHO Disease Outbreak News 599, published 2 May, assessed the MV Hondius cluster as low global risk under standard hantavirus protocol. The Swiss Andes confirmation, released after DON 599 closed, makes that rodent-only framing outdated before the bulletin was indexed.